Avid Bioservices Inc (NASDAQ:CDMO) currently has a daily average trading volume of 2.07M but it saw 1893697 shares traded in last market. With a market cap of 796.34M USD, the company’s current market price of $12.45 came falling about -0.08 while comparing to the previous closing price of $12.46. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.48 and as low as $5.90. In the recent trading on the day, stock has struck highest price mark of $12.42 while lowest mark touched by it was $12.47.
Taking a look at 20-day trading activity of Avid Bioservices Inc (CDMO) gives us an average price of $12.36, while its current price level is -0.24% below from 52-week high level whereas it is 111.02% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $12.30 while that of 200 days or SMA-200 reads an average of $9.96. A closer look into the stock’s movement over the week reveals that its volatility is standing at 0.39% during that period while stretching the period over a month that increases to 0.42%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 65.34 which implies that the stock is in neutral territory.
KeyBanc Capital Markets upgraded its recommendation for the stock as a “Overweight” from “Sector Weight” on March 14, 2023 while assigning a price target of $20.
Over the week, CDMO’s stock price is moving 0.24% up while it is 1.22% when we observe its performance for the past one month. Year-to-date it is 0.81% up and over the past year, the stock is showing an upside performance of 100.81%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of -0.04 while estimate for next year EPS is -0.31. In next quarter, company is expected to be making quarterly sales of $47.23M as analysts are expecting the sales for current fiscal year at $162.2M and seeing the company making $197.66M in sales next year. Moreover, analysts are in estimates of $42.41M for current-quarter revenue.
Currently, Avid Bioservices Inc’s total number of outstanding shares is 63.96M with 1.13% of that held by the insiders while 104.32% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -61.09% and return on equity (ROE) at -133.29%. Stock’s beta reads 1.39. Stock has a price to book (P/B) ratio of 17.77 while price to sale or P/S ratio amounts to 5.29. Its return on asset (ROA) is -39.04% on average.
